Searching for smart, safe news you can TRUST?
Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.
Searching for smart, safe news you can TRUST?
Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul
Tampa-St. Petersburg news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg
Photo: Sergei Fadeichev\TASS via Getty Images
Scientists at the National Institutes of Health announced the start of the first in-human trial for a universal influenza vaccine on Wednesday, known as H1ssF_3928.
Driving the news: The creation of a universal vaccine has been prioritized by the National Institute of Allergy and Infectious Diseases (NIAID) in part to protect against a pandemic strain that could kill millions like the 1918 flu pandemic. The H1ssF_3928 clinical trial, which will gradually enroll at least 53 adults, is ongoing at the NIH Clinical Center in Bethesda, Maryland.
Go deeper: Pandemic flu is #1 health security concern, per WH official